Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount.

https://ift.tt/2DbDDml support@endlesssupplies.biz (Endless Supplies .Biz) November 08, 2018 at 05:41PM
No comments:
Post a Comment